Title
Category
Credits
Event date
Cost
Early Detection and Diagnosis of Mild Cognitive Impairment and Alzheimers Disease
  • Cognitive Impairment
  • 0.58 AANP Contact Hours
  • 0.50 AMA PRA Category 1 Credit™
$0.00
In the context of a patient case presentation, expert faculty will highlight the stages of Alzheimer disease (AD) and the vital importance of early detection of mild cognitive impairment (MCI). They will discuss screening for MCI and current guidelines and standards of care for establishing a diagnosis of AD. The faculty will also examine the effects of increasingly more accessible neuroimaging and fluid markers on the diagnosis of AD, especially with the recent FDA approvals of anti-amyloid therapies.
Approaching Early Alzheimer Disease in Primary Care: Prompt Identification and Emerging Therapies
  • Alzheimer’s Disease
  • Cognitive Impairment
  • Pharmacology
  • 1.00 AANP Contact Hours
  • 0.33 AANP Pharmacology Contact Hours
  • 1.00 AMA PRA Category 1 Credit™
$0.00
Catching Alzheimer disease early is critical, yet studies show that 40% of cases may be missed. Join this session to hear a candid discussion between a primary care physician and a geriatric neurologist about how to identify patients with Alzheimer disease and how new and emerging therapies may benefit these patients. 

Pages